Abstract

ROLE OF ACT 12 AND ACT 13, A PHYTOCONSTITUENTS COMPLEX AS A POTENTIAL PROPHYLAXIS FOR MANAGEMENT OF COVID 19: A COMPREHENSIVE CASE STUDY REPORT

Shridhar Jitubhai Pandya* and Chetan Himmatbhai Savaliya

Abstract

The present pandemic condition needs a prophylaxis treatment against COVID-19. Drug discoveries from nutraceutical and Phytoconstituents are working on interventions to combat COVID-19 infection. The purpose of the study was to evaluate preventive action (prophylaxis) of the proposed intervention in around 800 healthy subjects with negative rapid antigen test, who have been administered with ACT12 and ACT 13 to explore the preventive potential of the intervention. Considering evidence from past research on ACT 12 and 13 together with the incidence of Positive rapid antigen rate in 800 subjects it can be concluded that ACT 12 and 13 could be a primary option to boost immunity against covid-19 and fight against infection. Surely the Phytoconstituents based composition of ACT 12 and 13 holds promise to patients and healthcare stakeholders as a safe and efficacious intervention in Covid 19 as prophylaxis and therapeutic as well.

Keywords: COVID-19, SARS-Cov-2, Nutraceutical, Phytoconstituents.